Cargando…
A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST)
Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate diagnosis and the skills of a multidisciplinary team. Surgery is the only curative treatment option and should be performed whenever feasible, by...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395485/ https://www.ncbi.nlm.nih.gov/pubmed/18521337 http://dx.doi.org/10.1080/1357714021000045217 |
_version_ | 1782155517397827584 |
---|---|
author | Judson, Ian Leahy, Michael Whelan, Jeremy Lorigan, Paul Verrill, Mark Grimer, Robert Robinson, Martin |
author_facet | Judson, Ian Leahy, Michael Whelan, Jeremy Lorigan, Paul Verrill, Mark Grimer, Robert Robinson, Martin |
author_sort | Judson, Ian |
collection | PubMed |
description | Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate diagnosis and the skills of a multidisciplinary team. Surgery is the only curative treatment option and should be performed whenever feasible, by experienced personnel. For patients with advanced unresectable or metastatic disease, the receptor tyrosine kinase inhibitor imatinib offers effective therapy and can provide effective palliation for the majority of patients with this disease. The background to this recent development and a guideline for the management of GIST is proposed. |
format | Text |
id | pubmed-2395485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23954852008-06-02 A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST) Judson, Ian Leahy, Michael Whelan, Jeremy Lorigan, Paul Verrill, Mark Grimer, Robert Robinson, Martin Sarcoma Research Article Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate diagnosis and the skills of a multidisciplinary team. Surgery is the only curative treatment option and should be performed whenever feasible, by experienced personnel. For patients with advanced unresectable or metastatic disease, the receptor tyrosine kinase inhibitor imatinib offers effective therapy and can provide effective palliation for the majority of patients with this disease. The background to this recent development and a guideline for the management of GIST is proposed. Hindawi Publishing Corporation 2002-09 /pmc/articles/PMC2395485/ /pubmed/18521337 http://dx.doi.org/10.1080/1357714021000045217 Text en Copyright © 2002 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Judson, Ian Leahy, Michael Whelan, Jeremy Lorigan, Paul Verrill, Mark Grimer, Robert Robinson, Martin A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST) |
title | A Guideline for the Management of Gastrointestinal Stromal
Tumour (GIST) |
title_full | A Guideline for the Management of Gastrointestinal Stromal
Tumour (GIST) |
title_fullStr | A Guideline for the Management of Gastrointestinal Stromal
Tumour (GIST) |
title_full_unstemmed | A Guideline for the Management of Gastrointestinal Stromal
Tumour (GIST) |
title_short | A Guideline for the Management of Gastrointestinal Stromal
Tumour (GIST) |
title_sort | guideline for the management of gastrointestinal stromal
tumour (gist) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395485/ https://www.ncbi.nlm.nih.gov/pubmed/18521337 http://dx.doi.org/10.1080/1357714021000045217 |
work_keys_str_mv | AT judsonian aguidelineforthemanagementofgastrointestinalstromaltumourgist AT leahymichael aguidelineforthemanagementofgastrointestinalstromaltumourgist AT whelanjeremy aguidelineforthemanagementofgastrointestinalstromaltumourgist AT loriganpaul aguidelineforthemanagementofgastrointestinalstromaltumourgist AT verrillmark aguidelineforthemanagementofgastrointestinalstromaltumourgist AT grimerrobert aguidelineforthemanagementofgastrointestinalstromaltumourgist AT robinsonmartin aguidelineforthemanagementofgastrointestinalstromaltumourgist AT judsonian guidelineforthemanagementofgastrointestinalstromaltumourgist AT leahymichael guidelineforthemanagementofgastrointestinalstromaltumourgist AT whelanjeremy guidelineforthemanagementofgastrointestinalstromaltumourgist AT loriganpaul guidelineforthemanagementofgastrointestinalstromaltumourgist AT verrillmark guidelineforthemanagementofgastrointestinalstromaltumourgist AT grimerrobert guidelineforthemanagementofgastrointestinalstromaltumourgist AT robinsonmartin guidelineforthemanagementofgastrointestinalstromaltumourgist |